Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Intention-to-treat analysis"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 595
Tytuł:
Intention-to-treat versus as-treated versus per-protocol approaches to analysis.
Autorzy:
Ahn E; Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
Kang H; Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Korean journal of anesthesiology [Korean J Anesthesiol] 2023 Dec; Vol. 76 (6), pp. 531-539. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Journal Article
MeSH Terms:
Research Design*
Humans ; Intention to Treat Analysis ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation study.
Autorzy:
Deng L; Montgomery Bell Academy, Nashville, TN, 37205, USA.
Hsu CY; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Shyr Y; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. .; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. .
Pokaż więcej
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2023 Feb 23; Vol. 23 (1), pp. 49. Date of Electronic Publication: 2023 Feb 23.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Treatment Switching*
Humans ; Sample Size ; Intention to Treat Analysis ; Computer Simulation ; Probability
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer according to intention-to-treat and per-protocol analysis: A systematic review and meta-analysis.
Autorzy:
Lee YS; Department of Internal Medicine, Inje University College of Medicine, Ilsan Paik Hospital, Goyang, Republic of Korea.
Lee JC; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Yang SY; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Kim J; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Hwang JH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Oct 30; Vol. 9 (1), pp. 15662. Date of Electronic Publication: 2019 Oct 30.
Typ publikacji:
Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms:
Intention to Treat Analysis*
Neoadjuvant Therapy*
Pancreatic Neoplasms/*therapy
Humans ; Pancreatic Neoplasms/surgery ; Pancreatic Neoplasms
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial.
Autorzy:
Ménard C; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada. .
Young S; Department of Oncology, London Health Sciences Centre, Western University, London, ON, Canada.
Zukotynski K; Departments of Medicine and Radiology, McMaster University, Hamilton, ON, Canada.; Department of Medical Imaging, Western University, London, ON, Canada.; Department of Radiology, University of British Columbia, Vancouver, BC, Canada.
Hamilton RJ; Department of Surgery (Urology), Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Bénard F; Department of Radiology, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada.
Yip S; Department of Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.
McCabe C; Institute for Health Economics, University of Alberta, Edmonton, AB, Canada.
Saad F; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada.
Brundage M; Department of Oncology, Kingston Regional Cancer Centre, Queen's University, Kingston, ON, Canada.
Nitulescu R; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada.; CHUM Center for the Integration and Analysis of Medical Data (CITADEL), Quebec, Canada.
Bauman G; Department of Oncology, London Health Sciences Centre, Western University, London, ON, Canada.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Mar 08; Vol. 22 (1), pp. 251. Date of Electronic Publication: 2022 Mar 08.
Typ publikacji:
Clinical Trial Protocol; Journal Article; Multicenter Study
MeSH Terms:
Positron Emission Tomography Computed Tomography*
Antigens, Neoplasm/*metabolism
Neoplasm Proteins/*metabolism
Prostatic Neoplasms/*therapy
Radiotherapy, Image-Guided/*methods
Surgery, Computer-Assisted/*methods
Adult ; Canada ; Clinical Trials, Phase III as Topic ; Equivalence Trials as Topic ; Fluorine Radioisotopes ; GPI-Linked Proteins/metabolism ; Humans ; Intention to Treat Analysis ; Male ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/therapy ; Neoplasm Staging/methods ; Pragmatic Clinical Trials as Topic ; Prospective Studies ; Prostatectomy/methods ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/metabolism ; Radiopharmaceuticals ; Radiotherapy, Intensity-Modulated/methods ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cysteamine as a topical management option for melasma.
Autorzy:
Hira SK; Department of Medicine, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Nalluri R; Department of Dermatology, Manchester University NHS Foundation Trust Varna pigmentation, Manchester, UK.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2022 Mar; Vol. 47 (3), pp. 646-647. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji:
Journal Article
MeSH Terms:
Cysteamine/*administration & dosage
Dermatologic Agents/*administration & dosage
Melanosis/*drug therapy
Administration, Topical ; Humans ; Intention to Treat Analysis ; Skin Cream ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Randomized controlled trial of early, small-volume formula supplementation among newborns: A study protocol.
Autorzy:
Ginsburg AS; University of Washington, Seattle, WA, United States of America.
Braima de Sa A; International Partnership for Human Development, Bissau, Guinea-Bissau.
Nankabirwa V; Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.; Department of Global Public Health and Primary Care, Centre for Intervention Science in Maternal and Child Health (CISMAC), Centre for International Health, University of Bergen, Bergen, Norway.
Co R; International Partnership for Human Development, Bissau, Guinea-Bissau.
Murungi J; Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.
Kim MO; Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, United States of America.
Brim R; Department of Pediatrics, University of California, San Francisco, CA, United States of America.
Namiiro F; Mulago Specialized Women's and Neonatal Hospital, Kampala, Uganda.
Namugga O; Department of Epidemiology and Biostatistics, School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.; Department of Global Public Health and Primary Care, Centre for Intervention Science in Maternal and Child Health (CISMAC), Centre for International Health, University of Bergen, Bergen, Norway.
Hartigan-O'Connor DJ; Department of Medical Microbiology and Immunology and the California National Primate Research Center, University of California, Davis, CA, United States of America.; Division of Experimental Medicine, University of California, San Francisco, CA, United States of America.
Roberts SB; Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, United States of America.
Flaherman V; Department of Pediatrics, University of California, San Francisco, CA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Feb 04; Vol. 17 (2), pp. e0263129. Date of Electronic Publication: 2022 Feb 04 (Print Publication: 2022).
Typ publikacji:
Clinical Trial Protocol; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Infant Formula*
Malnutrition*/prevention & control
Female ; Humans ; Infant, Newborn ; Dietary Supplements ; Food, Formulated ; Gastrointestinal Microbiome ; Guinea-Bissau ; Infant Nutritional Physiological Phenomena ; Infant, Low Birth Weight ; Intention to Treat Analysis ; Mothers ; Patient Safety ; Prospective Studies ; Thinness ; Treatment Outcome ; Uganda ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial.
Autorzy:
van Erp IAM; University Neurosurgical Center Holland, Leiden University Medical Center, Haaglanden Medical Center and Haga Teaching Hospital, Albinusdreef 2, J-11-R-83, 2333 ZA, Leiden, Hague, The Netherlands. i.a.m.van_.
van Essen TA; University Neurosurgical Center Holland, Leiden University Medical Center, Haaglanden Medical Center and Haga Teaching Hospital, Albinusdreef 2, J-11-R-83, 2333 ZA, Leiden, Hague, The Netherlands.
Fluiter K; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
van Zwet E; Department of Biomedical Data Science, Leiden University Medical Center, Leiden, The Netherlands.
van Vliet P; Department of Intensive Care, Haaglanden Medical Center, The Hague, The Netherlands.
Baas F; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Haitsma I; Department of Neurosurgery, Erasmus MC - University Medical Center, Rotterdam, The Netherlands.
Verbaan D; Neurosurgical Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Coert B; Neurosurgical Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands.
de Ruiter GCW; University Neurosurgical Center Holland, Leiden University Medical Center, Haaglanden Medical Center and Haga Teaching Hospital, Albinusdreef 2, J-11-R-83, 2333 ZA, Leiden, Hague, The Netherlands.
Moojen WA; University Neurosurgical Center Holland, Leiden University Medical Center, Haaglanden Medical Center and Haga Teaching Hospital, Albinusdreef 2, J-11-R-83, 2333 ZA, Leiden, Hague, The Netherlands.
van der Jagt M; Department of Intensive Care Adults, Erasmus MC - University Medical Center, Rotterdam, The Netherlands.
Peul WC; University Neurosurgical Center Holland, Leiden University Medical Center, Haaglanden Medical Center and Haga Teaching Hospital, Albinusdreef 2, J-11-R-83, 2333 ZA, Leiden, Hague, The Netherlands.
Pokaż więcej
Źródło:
Trials [Trials] 2021 Dec 04; Vol. 22 (1), pp. 874. Date of Electronic Publication: 2021 Dec 04.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Brain Injuries*
Brain Injuries, Traumatic*/diagnosis
Brain Injuries, Traumatic*/drug therapy
Adult ; Humans ; Intention to Treat Analysis ; Multicenter Studies as Topic ; Neuroinflammatory Diseases ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis.
Autorzy:
Xin Y; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China. .
Shen G; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China. .
Zheng Y; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China. .
Guan Y; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China.
Huo X; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China.
Li J; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China.
Ren D; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China.
Zhao F; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China.
Liu Z; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China.
Li Z; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China.
Zhao J; Breast Disease Diagnosis and Treatment Center of Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University, Xining, 810000, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2021 Nov 23; Vol. 21 (1), pp. 1261. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Immune Checkpoint Inhibitors*/adverse effects
Immune Checkpoint Inhibitors*/therapeutic use
Neoadjuvant Therapy*/adverse effects
Neoadjuvant Therapy*/methods
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/pathology
Female ; Humans ; Chemotherapy, Adjuvant ; Diarrhea/chemically induced ; Hyperthyroidism/chemically induced ; Hypothyroidism/chemically induced ; Intention to Treat Analysis ; Progression-Free Survival ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Vomiting/chemically induced
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Understanding the Intention-to-treat Principle in Randomized Controlled Trials.
Autorzy:
McCoy CE; University of California, Irvine, School of Medicine and Medical Center, Department of Emergency Medicine, Orange, California.
Pokaż więcej
Źródło:
The western journal of emergency medicine [West J Emerg Med] 2017 Oct; Vol. 18 (6), pp. 1075-1078. Date of Electronic Publication: 2017 Sep 18.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Bias*
Intention to Treat Analysis*
Randomized Controlled Trials as Topic*
Humans ; Prognosis ; Prospective Studies ; Research Design
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Cost effectiveness of a controlled lifestyle intervention for pregnant women with obesity.
Autorzy:
Gyllensten H; Institute of Health and Care Sciences, University of Gothenburg, Box 457, SE-405 30, Göteborg, Sweden. .; Centre for Person-Centred Care - GPCC, University of Gothenburg, Gothenburg, Sweden. .; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. .
Haby K; Institute of Health and Care Sciences, University of Gothenburg, Box 457, SE-405 30, Göteborg, Sweden.; Region Västra Götaland, Research and Development Primary Health Care, Gothenburg, Sweden.
Berg M; Institute of Health and Care Sciences, University of Gothenburg, Box 457, SE-405 30, Göteborg, Sweden.; Centre for Person-Centred Care - GPCC, University of Gothenburg, Gothenburg, Sweden.; Region Västra Götaland, Sahlgrenska University Hospital, Department of Obstetrics, Gothenburg, Sweden.
Premberg Å; Institute of Health and Care Sciences, University of Gothenburg, Box 457, SE-405 30, Göteborg, Sweden.; Region Västra Götaland, Research and Development Primary Health Care, Gothenburg, Sweden.
Pokaż więcej
Źródło:
BMC pregnancy and childbirth [BMC Pregnancy Childbirth] 2021 Sep 21; Vol. 21 (1), pp. 639. Date of Electronic Publication: 2021 Sep 21.
Typ publikacji:
Adaptive Clinical Trial; Clinical Trial; Journal Article
MeSH Terms:
Gestational Weight Gain*
Health Promotion/*methods
Obesity/*psychology
Patient-Centered Care/*methods
Adult ; Cost-Benefit Analysis ; Female ; Health Behavior ; Health Promotion/economics ; Humans ; Intention to Treat Analysis ; Life Style ; Motivation ; Patient-Centered Care/economics ; Pregnancy ; Prenatal Care/methods ; Sweden
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Comparison of ocular surface assessment and adherence between preserved and preservative-free latanoprost in glaucoma: a parallel-grouped randomized trial.
Autorzy:
Kim DW; Department of Ophthalmology, Kyungpook National University School of Medicine, Daegu, Republic of Korea.
Shin J; Department of Ophthalmology, College of Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.; Department of Ophthalmology, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Hospital, Yangsan, Republic of Korea.
Lee CK; Department of Ophthalmology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
Kim M; Department of Ophthalmology, CHA Bundang Medical Center, CHA University, 59 Yatap-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-712, Republic of Korea.
Lee S; Department of Ophthalmology, CHA Bundang Medical Center, CHA University, 59 Yatap-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-712, Republic of Korea.
Rho S; Department of Ophthalmology, CHA Bundang Medical Center, CHA University, 59 Yatap-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 463-712, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jul 22; Vol. 11 (1), pp. 14971. Date of Electronic Publication: 2021 Jul 22.
Typ publikacji:
Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Glaucoma, Open-Angle/*drug therapy
Latanoprost/*administration & dosage
Ocular Hypertension/*drug therapy
Ophthalmic Solutions/*administration & dosage
Aged ; Drug Administration Schedule ; Female ; Humans ; Intention to Treat Analysis ; Latanoprost/chemistry ; Latanoprost/pharmacology ; Male ; Middle Aged ; Ophthalmic Solutions/chemistry ; Ophthalmic Solutions/pharmacology ; Preservatives, Pharmaceutical/chemistry ; Treatment Adherence and Compliance ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trial.
Autorzy:
Zheng L; Department of Gastroenterology, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, 23 Nanhu Rd, Nanjing, 210017, China.
Lu W; Department of Internal Medicine, Jiangsu Provincial Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, 155 Hanzhong Rd., Nanjing, 210029, China.
Xiao Q; The School of Medicine, Washington University, 660 S Euclid Ave., St. Louis, MO, 63110, USA.
Lai Y; Department of Gastroenterology, Beijing Xuanwu Hospital of Chinese Medicine, 8 Wanming Rd., Beijing, 100050, China.
Fan H; Department of Integrated Chinese Medicine and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Liberty Rd., Wuhan, 430022, China.
Sun Y; The State Key Laboratory Cultivation Base for TCM Quality and Efficacy, The School of Medicine and Life Sciences, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, China.
Huang D; Department of Gastroenterology, Beijing Xuanwu Hospital of Chinese Medicine, 8 Wanming Rd., Beijing, 100050, China.
Wang Y; Department of Gastroenterology, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, 23 Nanhu Rd, Nanjing, 210017, China.
Li Z; Department of Gastroenterology, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, 23 Nanhu Rd, Nanjing, 210017, China.
Jiang Z; Department of Gastroenterology, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, 23 Nanhu Rd, Nanjing, 210017, China.
Liu X; Department of Integrated Chinese Medicine and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Liberty Rd., Wuhan, 430022, China.
Zhang L; Department of Integrated Chinese Medicine and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Liberty Rd., Wuhan, 430022, China.
Zuo D; Department of Integrated Chinese Medicine and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Liberty Rd., Wuhan, 430022, China.
Shou Z; Department of Integrated Chinese Medicine and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Liberty Rd., Wuhan, 430022, China.
Tang Q; Department of Integrated Chinese Medicine and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Liberty Rd., Wuhan, 430022, China.
Huang H; The Macrohard Institute of Health, 231 North Ave., Battle Creek, MI, 49017, USA.
Yang Y; The Macrohard Institute of Health, 231 North Ave., Battle Creek, MI, 49017, USA.
Tang Z; The State Key Laboratory Cultivation Base for TCM Quality and Efficacy, The School of Medicine and Life Sciences, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, 210023, China.
Xiao J; The Macrohard Institute of Health, 231 North Ave., Battle Creek, MI, 49017, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jul 06; Vol. 11 (1), pp. 13894. Date of Electronic Publication: 2021 Jul 06.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Irritable Bowel Syndrome/*drug therapy
Morpholines/*therapeutic use
Adult ; Confidence Intervals ; Endpoint Determination ; Female ; Humans ; Intention to Treat Analysis ; Kaplan-Meier Estimate ; Male ; Morpholines/pharmacology ; Odds Ratio ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Outcomes and factors impacting use of axicabtagene ciloleucel in patients with relapsed or refractory large B-cell lymphoma: results from an intention-to-treat analysis.
Autorzy:
Mian A; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Wei W; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Winter AM; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Khouri J; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Jagadeesh D; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Anwer F; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Gerds AT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Dean RM; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Sobecks R; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Pohlman B; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Hamilton BK; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Majhail NS; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Hill BT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2021 Jun; Vol. 62 (6), pp. 1344-1352. Date of Electronic Publication: 2020 Dec 29.
Typ publikacji:
Journal Article
MeSH Terms:
Antigens, CD19*/therapeutic use
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Biological Products ; Humans ; Immunotherapy, Adoptive ; Intention to Treat Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effectiveness of self-help workbook intervention on quality of life in cancer patients receiving chemotherapy: results of a randomized controlled trial.
Autorzy:
Takano T; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. .; Section of Liaison Psychiatry and Palliative Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. .
Matsuda A; Department of Hygiene and Public Health, School of Medicine, Teikyo University, Tokyo, Japan.
Ishizuka N; Section of Liaison Psychiatry and Palliative Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Ozaki Y; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Suyama K; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.; Kumamoto University Hospital Cancer Center, Kumamoto, Japan.
Tanabe Y; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Miura Y; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Matsushima E; Section of Liaison Psychiatry and Palliative Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2021 May 22; Vol. 21 (1), pp. 588. Date of Electronic Publication: 2021 May 22.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Adaptation, Psychological*
Quality of Life*
Antineoplastic Agents/*therapeutic use
Neoplasms/*drug therapy
Patient Navigation/*methods
Adult ; Aged ; Aged, 80 and over ; Feasibility Studies ; Female ; Humans ; Intention to Treat Analysis ; Male ; Middle Aged ; Neoplasms/psychology ; Patient Education as Topic/methods ; Psychological Distress ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review.
Autorzy:
Bai AD; Division of Infectious Diseases, McMaster University, Hamilton, ON, Canada. .; McMaster University Infectious Diseases Residency Program, JCC 3-71 at Juravinski Cancer Centre, 699 Concession St, Hamilton, ON, L8V 5C2, Canada. .
Komorowski AS; Division of Medical Microbiology, McMaster, University, Hamilton, ON, Canada.
Lo CKL; Division of Infectious Diseases, McMaster University, Hamilton, ON, Canada.
Tandon P; Global Health Office, McMaster University, Hamilton, ON, Canada.
Li XX; Division of Infectious Diseases, McMaster University, Hamilton, ON, Canada.; Division of Medical Microbiology, McMaster, University, Hamilton, ON, Canada.
Mokashi V; Division of Infectious Diseases, McMaster University, Hamilton, ON, Canada.
Cvetkovic A; Division of Infectious Diseases, McMaster University, Hamilton, ON, Canada.
Findlater A; Division of Infectious Diseases, McMaster University, Hamilton, ON, Canada.
Liang L; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
Tomlinson G; Department of Medicine, University Health Network and Mount Sinai Hospital, Toronto, ON, Canada.; Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Loeb M; Division of Infectious Diseases, McMaster University, Hamilton, ON, Canada.
Mertz D; Division of Infectious Diseases, McMaster University, Hamilton, ON, Canada.
Pokaż więcej
Corporate Authors:
McMaster Infectious Diseases Fellow Research Group
Źródło:
BMC medical research methodology [BMC Med Res Methodol] 2021 Apr 19; Vol. 21 (1), pp. 75. Date of Electronic Publication: 2021 Apr 19.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
Anti-Bacterial Agents*
Humans ; Bias ; Clinical Protocols ; Intention to Treat Analysis ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Intention-to-treat versus as-treated versus per-protocol approaches to analysis
Autorzy:
EunJin Ahn
Hyun Kang
Pokaż więcej
Temat:
data analysis
intention to treat analysis
intervention study
randomized controlled trial
statistics
treatment outcome
Anesthesiology
RD78.3-87.3
Źródło:
Korean Journal of Anesthesiology, Vol 76, Iss 6, Pp 531-539 (2023)
Opis pliku:
electronic resource
Relacje:
http://ekja.org/upload/pdf/kja-23278.pdf; https://doaj.org/toc/2005-6419; https://doaj.org/toc/2005-7563
Dostęp URL:
https://doaj.org/article/970d184d004e490f8c71cdbb1e43ad1c  Link otwiera się w nowym oknie
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Statistical analysis plan for a randomized controlled trial examining pedometer-based walking intervention in patients with heart failure with reduced ejection fraction: the WATCHFUL trial
Autorzy:
Vetrovsky, TomasAff1, IDs13063023075165_cor1
Siranec, Michal
Frybova, Tereza
Gant, Iulian
Semerad, Miroslav
Miklikova, Marie
Bunc, Vaclav
Vesely, JiriAff4, Aff5
Stastny, Jiri
Griva, MartinAff6, Aff7
Precek, Jan
Pelouch, RadekAff9, Aff10
Parenica, Jiri
Jarkovsky, Jiri
Belohlavek, Jan
Pokaż więcej
Źródło:
Trials. 24(1)
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Novel community health worker strategy for HIV service engagement in a hyperendemic community in Rakai, Uganda: A pragmatic, cluster-randomized trial.
Autorzy:
Chang LW; Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; Rakai Health Sciences Program, Rakai, Uganda.
Mbabali I; Rakai Health Sciences Program, Rakai, Uganda.
Hutton H; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
Amico KR; Department of Health Behavior Health Education, University of Michigan, Ann Arbor, Michigan, United States of America.
Kong X; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
Mulamba J; Rakai Health Sciences Program, Rakai, Uganda.
Anok A; Rakai Health Sciences Program, Rakai, Uganda.
Ssekasanvu J; Rakai Health Sciences Program, Rakai, Uganda.
Long A; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Thomas AG; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Thomas K; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Bugos E; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Pollard R; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
van Wickle K; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Kennedy CE; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; Rakai Health Sciences Program, Rakai, Uganda.
Nalugoda F; Rakai Health Sciences Program, Rakai, Uganda.
Serwadda D; Rakai Health Sciences Program, Rakai, Uganda.
Bollinger RC; Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
Quinn TC; Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.; Laboratory of Immunoregulation, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Reynolds SJ; Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.; Rakai Health Sciences Program, Rakai, Uganda.; Laboratory of Immunoregulation, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Gray RH; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; Rakai Health Sciences Program, Rakai, Uganda.
Wawer MJ; Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.; Rakai Health Sciences Program, Rakai, Uganda.
Nakigozi G; Rakai Health Sciences Program, Rakai, Uganda.
Pokaż więcej
Źródło:
PLoS medicine [PLoS Med] 2021 Jan 06; Vol. 18 (1), pp. e1003475. Date of Electronic Publication: 2021 Jan 06 (Print Publication: 2021).
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms:
Community Health Workers*
Mobile Applications*
Motivational Interviewing*
HIV Infections/*prevention & control
Health Promotion/*methods
Adolescent ; Adult ; Anti-HIV Agents/therapeutic use ; Circumcision, Male ; Condoms ; Female ; HIV Infections/epidemiology ; Humans ; Incidence ; Intention to Treat Analysis ; Male ; Middle Aged ; Prevalence ; Uganda/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Two-year outcomes of Whānau Pakari, a multi-disciplinary assessment and intervention for children and adolescents with weight issues: A randomized clinical trial.
Autorzy:
Anderson YC; Department of Paediatrics, Taranaki District Health Board, New Plymouth, New Zealand.; Liggins Institute, University of Auckland, Auckland, New Zealand.; Department of Paediatrics, Child and Youth Health, University of Auckland, Auckland, New Zealand.
Wynter LE; Department of Paediatrics, Taranaki District Health Board, New Plymouth, New Zealand.
O'Sullivan NA; Department of Paediatrics, Taranaki District Health Board, New Plymouth, New Zealand.
Wild CEK; Liggins Institute, University of Auckland, Auckland, New Zealand.
Grant CC; Department of Paediatrics, Child and Youth Health, University of Auckland, Auckland, New Zealand.; Starship Children's Hospital, Auckland District Health Board, Auckland, New Zealand.
Cave TL; Liggins Institute, University of Auckland, Auckland, New Zealand.
Derraik JGB; Liggins Institute, University of Auckland, Auckland, New Zealand.; A Better Start - National Science Challenge, University of Auckland, Auckland, New Zealand.
Hofman PL; Liggins Institute, University of Auckland, Auckland, New Zealand.; Starship Children's Hospital, Auckland District Health Board, Auckland, New Zealand.
Pokaż więcej
Źródło:
Pediatric obesity [Pediatr Obes] 2021 Jan; Vol. 16 (1), pp. e12693. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Pediatric Obesity/*diagnosis
Pediatric Obesity/*therapy
Weight Reduction Programs/*methods
Adolescent ; Body Mass Index ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Health Behavior ; Humans ; Intention to Treat Analysis ; Linear Models ; Male ; New Zealand ; Pediatric Obesity/psychology ; Treatment Outcome ; Weight Reduction Programs/organization & administration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy of blue light vs. fluocinolone 0.025% ointment in treatment of localized plaque psoriasis.
Autorzy:
Memarzadeh Z; Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Layegh P; Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Maleki M; Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Sazgarnia A; Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Morovatdar N; Clinical Research Unit, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Shiva F; Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Ferezeghi MR; Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Pokaż więcej
Źródło:
Photodermatology, photoimmunology & photomedicine [Photodermatol Photoimmunol Photomed] 2021 Jan; Vol. 37 (1), pp. 78-81. Date of Electronic Publication: 2020 Aug 02.
Typ publikacji:
Letter
MeSH Terms:
Fluocinolone Acetonide/*analogs & derivatives
Glucocorticoids/*therapeutic use
Phototherapy/*methods
Psoriasis/*therapy
Administration, Topical ; Adult ; Female ; Fluocinolone Acetonide/therapeutic use ; Humans ; Intention to Treat Analysis ; Male ; Severity of Illness Index
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 595

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies